BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8358230)

  • 1. Action of rat liver Gal beta 1-4GlcNAc alpha(2-6)-sialyltransferase on Man beta 1-4GlcNAc beta-OMe, GalNAc beta 1-4GlcNAc beta-OMe, Glc beta 1-4GlcNAc beta-OMe and GlcNAc beta 1-4GlcNAc beta-OMe as synthetic substrates.
    Hokke CH; van der Ven JG; Kamerling JP; Vliegenthart JF
    Glycoconj J; 1993 Feb; 10(1):82-90. PubMed ID: 8358230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver.
    Weinstein J; de Souza-e-Silva U; Paulson JC
    J Biol Chem; 1982 Nov; 257(22):13835-44. PubMed ID: 7142179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of Gal beta 1,4GlcNAc alpha-2,6- and Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferases by affinity chromatography.
    Sabesan S; Paulson JC; Weinstein J
    Methods Enzymol; 1994; 247():237-43. PubMed ID: 7898356
    [No Abstract]   [Full Text] [Related]  

  • 4. Branch specificity of bovine colostrum CMP-sialic acid: Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase. Sialylation of bi-, tri-, and tetraantennary oligosaccharides and glycopeptides of the N-acetyllactosamine type.
    Joziasse DH; Schiphorst WE; Van den Eijnden DH; Van Kuik JA; Van Halbeek H; Vliegenthart JF
    J Biol Chem; 1987 Feb; 262(5):2025-33. PubMed ID: 3546284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
    Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
    J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human liver and human placenta both contain CMP-NeuAc:Gal beta 1-->4GlcNAc-R alpha 2-->3- as well as alpha 2-->6-sialyltransferase activity.
    Nemansky M; Schiphorst WE; Koeleman CA; Van den Eijnden DH
    FEBS Lett; 1992 Nov; 312(1):31-6. PubMed ID: 1426235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic characterization of CMP-NeuAc:Gal beta 1-4GlcNAc-R alpha(2-3)-sialyltransferase from human placenta.
    Nemansky M; van den Eijnden DH
    Glycoconj J; 1993 Feb; 10(1):99-108. PubMed ID: 8395270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of sialyltransferases from rat liver Golgi membranes by a cathepsin D-like proteinase: comparison of the release of Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase, Gal beta 1-3(4)GlcNAc alpha 2-3 sialyltransferase and lactosylceramide alpha 2-3 sialyltransferase (SAT-1).
    Richardson K; Jamieson JC
    Comp Biochem Physiol B Biochem Mol Biol; 1995 Feb; 110(2):445-50. PubMed ID: 7719647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
    Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
    Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel UDP-Gal:GalNAc beta 1-4GlcNAc-R beta 1-3-galactosyltransferase in the connective tissue of the snail Lymnaea stagnalis.
    Mulder H; Schachter H; De Jong-Brink M; Van der Ven JG; Kamerling JP; Vliegenthart JF
    Eur J Biochem; 1991 Oct; 201(2):459-65. PubMed ID: 1935942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
    Hamamoto T; Kurosawa N; Lee YC; Tsuji S
    Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mouse Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase in an insoluble form in Escherichia coli and partial renaturation.
    Hamamoto T; Lee YC; Kurosawa N; Nakaoka T; Kojima N; Tsuji S
    Bioorg Med Chem; 1994 Feb; 2(2):79-84. PubMed ID: 7922126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analogues.
    Van Dorst JA; Tikkanen JM; Krezdorn CH; Streiff MB; Berger EG; Van Kuik JA; Kamerling JP; Vliegenthart JF
    Eur J Biochem; 1996 Dec; 242(3):674-81. PubMed ID: 9022696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of alpha (2-6)-sialyltransferase from human liver.
    Sticher U; Gross HJ; Brossmer R
    Glycoconj J; 1991 Feb; 8(1):45-54. PubMed ID: 1823612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver.
    Weinstein J; de Souza-e-Silva U; Paulson JC
    J Biol Chem; 1982 Nov; 257(22):13845-53. PubMed ID: 7142180
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences.
    Beyer TA; Rearick JI; Paulson JC; Prieels JP; Sadler JE; Hill RL
    J Biol Chem; 1979 Dec; 254(24):12531-4. PubMed ID: 500730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of GalNAc beta(1-4)GlcNAc beta-OMe into GalNAc beta (1-4)-[Fuc alpha(1-3)]GlcNAc beta-OMe using human milk alpha 3/4-fucosyltransferase. Synthesis of a novel terminal element in glycoprotein glycans.
    Bergwerff AA; van Kuik JA; Schiphorst WE; Koeleman CA; van den Eijnden DH; Kamerling JP; Vliegenthart JF
    FEBS Lett; 1993 Nov; 334(1):133-8. PubMed ID: 7901053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine liver (2-->3)-alpha-sialyltransferase: substrate specificity studies and application of the immobilized enzyme to the synthesis of various sialylated oligosaccharide sequences.
    Lubineau A; Basset-Carpentier K; Augé C
    Carbohydr Res; 1997 May; 300(2):161-7. PubMed ID: 9203341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligosaccharides derived by keratanase II digestion of bovine articular cartilage keratan sulphates.
    Brown GM; Huckerby TN; Nieduszynski IA
    Eur J Biochem; 1994 Sep; 224(2):281-308. PubMed ID: 7925342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.